CN103735500A - 盐酸他喷他多注射液及其制备方法 - Google Patents
盐酸他喷他多注射液及其制备方法 Download PDFInfo
- Publication number
- CN103735500A CN103735500A CN201410042768.5A CN201410042768A CN103735500A CN 103735500 A CN103735500 A CN 103735500A CN 201410042768 A CN201410042768 A CN 201410042768A CN 103735500 A CN103735500 A CN 103735500A
- Authority
- CN
- China
- Prior art keywords
- injection
- tapentadol hydrochloride
- sodium
- tapentadol
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410042768.5A CN103735500B (zh) | 2014-01-28 | 2014-01-28 | 盐酸他喷他多注射液及其制备方法 |
PCT/CN2014/071658 WO2015113200A1 (zh) | 2014-01-28 | 2014-03-03 | 盐酸他喷他多注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410042768.5A CN103735500B (zh) | 2014-01-28 | 2014-01-28 | 盐酸他喷他多注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103735500A true CN103735500A (zh) | 2014-04-23 |
CN103735500B CN103735500B (zh) | 2016-01-20 |
Family
ID=50492621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410042768.5A Active CN103735500B (zh) | 2014-01-28 | 2014-01-28 | 盐酸他喷他多注射液及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103735500B (zh) |
WO (1) | WO2015113200A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105037180A (zh) * | 2015-04-19 | 2015-11-11 | 安徽省逸欣铭医药科技有限公司 | 一种双重作用的中枢性镇痛新化合物、制备方法及用途 |
WO2018055070A1 (en) | 2016-09-23 | 2018-03-29 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
CN108066820A (zh) * | 2017-12-28 | 2018-05-25 | 江苏艾尔康生物医药科技有限公司 | 一种自体真皮成纤维细胞注射液 |
WO2018153947A1 (en) | 2017-02-23 | 2018-08-30 | Grünenthal GmbH | Tapentadol as local anesthetic |
CN110191708A (zh) * | 2017-01-11 | 2019-08-30 | 托伦特药物有限公司 | 他喷他多鼻用组合物 |
US11013701B2 (en) | 2015-03-27 | 2021-05-25 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
US11547678B2 (en) | 2011-03-04 | 2023-01-10 | Gruenenthal Gmbh | Aqueous pharmaceutical formulation of tapentadol for oral administration |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103501775A (zh) * | 2011-03-04 | 2014-01-08 | 格吕伦塔尔有限公司 | 他喷他多的胃肠外给药 |
-
2014
- 2014-01-28 CN CN201410042768.5A patent/CN103735500B/zh active Active
- 2014-03-03 WO PCT/CN2014/071658 patent/WO2015113200A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103501775A (zh) * | 2011-03-04 | 2014-01-08 | 格吕伦塔尔有限公司 | 他喷他多的胃肠外给药 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11547678B2 (en) | 2011-03-04 | 2023-01-10 | Gruenenthal Gmbh | Aqueous pharmaceutical formulation of tapentadol for oral administration |
US11013701B2 (en) | 2015-03-27 | 2021-05-25 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
CN105037180A (zh) * | 2015-04-19 | 2015-11-11 | 安徽省逸欣铭医药科技有限公司 | 一种双重作用的中枢性镇痛新化合物、制备方法及用途 |
WO2018055070A1 (en) | 2016-09-23 | 2018-03-29 | Grünenthal GmbH | Stable formulation for parenteral administration of tapentadol |
CN109996533A (zh) * | 2016-09-23 | 2019-07-09 | 格吕伦塔尔有限公司 | 用于肠胃外施用他喷他多的稳定制剂 |
JP2019529442A (ja) * | 2016-09-23 | 2019-10-17 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | タペンタドールの非経口投与用安定製剤 |
AU2017329964B2 (en) * | 2016-09-23 | 2022-10-06 | Grünenthal GmbH | Stable formulation for parenteral administration of Tapentadol |
JP7160799B2 (ja) | 2016-09-23 | 2022-10-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | タペンタドールの非経口投与用安定製剤 |
CN110191708A (zh) * | 2017-01-11 | 2019-08-30 | 托伦特药物有限公司 | 他喷他多鼻用组合物 |
WO2018153947A1 (en) | 2017-02-23 | 2018-08-30 | Grünenthal GmbH | Tapentadol as local anesthetic |
CN108066820A (zh) * | 2017-12-28 | 2018-05-25 | 江苏艾尔康生物医药科技有限公司 | 一种自体真皮成纤维细胞注射液 |
Also Published As
Publication number | Publication date |
---|---|
WO2015113200A1 (zh) | 2015-08-06 |
CN103735500B (zh) | 2016-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103735500B (zh) | 盐酸他喷他多注射液及其制备方法 | |
US8017623B2 (en) | Dextromethorphan hydrochloride | |
Smith et al. | Introduction to the principles of Drug Design | |
NZ264774A (en) | Use of fluoxetine, venlafaxine, milnacipran and duloxetine with a synergist in pharmaceutical compositions | |
CN109381471A (zh) | 包含柠檬苦素类化合物和双胍类化合物的组合产品 | |
CN105338970B (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
CN102740842A (zh) | 反式降舍曲林的制剂、盐和多晶型物及其应用 | |
WO2008022557A1 (fr) | Composition liquide de sirolimus | |
CN109771503A (zh) | 一种花椒提取物及其应用 | |
CN102895278B (zh) | 牛蒡苷及苷元在制备抗帕金森病药物中的用途 | |
CN110179809A (zh) | 柴胡皂苷b2在制备抗抑郁症药物中的应用 | |
CN100349568C (zh) | 一种静脉给药的银杏内酯b针剂及其制备方法、应用 | |
CN101331112B (zh) | 一种联苯乙酸盐及其制备方法与应用 | |
CN105311622B (zh) | 一种治疗疼痛的联合用药物及其制剂、制备方法 | |
CN110302386A (zh) | 包含柠檬苦素类化合物和磺酰脲类药物的组合产品 | |
CN109908201A (zh) | 一种中药组合物提取物及制备工艺与应用 | |
CN102716120B (zh) | (3r)-去-o-甲基毛狄泼老素在制备预防或治疗抑郁症的药物中的用途 | |
US9943560B2 (en) | Medical compositions containing liquorice extracts with synergistic effect | |
CN103690535A (zh) | 盐酸去亚甲基小檗碱在制备预防和/或治疗肝纤维化药物中的应用 | |
Modell | Problems in the Evaluation of Drugs in Man | |
CN106177962A (zh) | 含沙格雷酯的药物组合物用于治疗或预防脂肪肝、肝纤维化和/或肝损伤的用途 | |
CN104224796B (zh) | 齐墩果烷型三萜类酯衍生物抗神经退行性药物用途 | |
CN105919991B (zh) | 泽兰素在制备治疗抑郁症药物中的应用 | |
CN102481265A (zh) | 保护和治疗神经损伤的方法和组合物 | |
CN107129453A (zh) | 化合物、毒蕈碱m受体拮抗剂、组合物及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160823 Address after: Jiangsu province Taizhou City Xinglin road 225300 No. 12 building 17 Patentee after: Curegen (Jiangsu) Pharmaceuticals Inc. Patentee after: Wu Renrong Address before: 18, block 1, international finance center, No. 210000, Hanzhoung Road, Qinhuai District, Jiangsu, Nanjing, China E Patentee before: JIANGSU HUAZE MEDICINE SCIENCE & TECHNOLOGY CO., LTD. Patentee before: Wu Renrong |
|
TR01 | Transfer of patent right |
Effective date of registration: 20201110 Address after: Jiangsu province Taizhou City Xinglin road 225300 No. 12 building 17 Patentee after: Jiangsu Huatai Chenguang Pharmaceutical Co.,Ltd. Address before: Jiangsu province Taizhou City Xinglin road 225300 No. 12 building 17 Patentee before: Jiangsu Huatai Chenguang Pharmaceutical Co.,Ltd. Patentee before: Wu Renrong |
|
TR01 | Transfer of patent right |